X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-07-01 | CERE | Coles N Anthony | Dir | S - Sale+OE | $41.18 | -25,000 | 25,928 | -49% | -$1,029,535 | |||||
| D | 2024-06-03 | CERE | Coles N Anthony | Dir | S - Sale+OE | $40.61 | -50,000 | 15,638 | -76% | -$2,030,520 | |||||
| D | 2024-05-10 | CERE | Coles N Anthony | Dir | S - Sale+OE | $42.10 | -50,000 | 15,638 | -76% | -$2,105,125 | |||||
| D | 2024-04-01 | CERE | Coles N Anthony | Dir | S - Sale+OE | $42.33 | -50,000 | 15,638 | -76% | -$2,116,640 | |||||
| D | 2024-03-04 | CERE | Coles N Anthony | Dir | S - Sale+OE | $41.01 | -50,000 | 15,638 | -76% | -$2,050,550 | |||||
| D | 2024-02-29 | CERE | Coles N Anthony | Dir | S - Sale+OE | $41.16 | -50,000 | 15,638 | -76% | -$2,057,890 | |||||
| D | 2024-02-07 | CERE | Renger John | Chief Scientific Officer | S - Sale+OE | $41.54 | -2,161 | 6,370 | -25% | -$89,777 | |||||
| D | 2024-02-07 | CERE | Coles N Anthony | Dir | S - Sale+OE | $41.54 | -2,506 | 15,638 | -14% | -$104,110 | |||||
| D | 2024-01-02 | CERE | Coles N Anthony | Dir | S - Sale+OE | $42.24 | -50,000 | 2,704 | -95% | -$2,111,815 | |||||
| D | 2023-12-26 | CERE | Sanchez Ramiro | Chief Medical Officer | S - Sale+OE | $42.47 | -10,000 | 14,673 | -41% | -$424,700 | |||||
| D | 2023-12-22 | CERE | Dipietro Kenneth | CHRO | S - Sale+OE | $41.45 | -8,000 | 24,663 | -24% | -$331,608 | |||||
| D | 2023-12-20 | CERE | Bodenrader Mark | See Remarks | S - Sale+OE | $41.42 | -7,889 | 17,724 | -31% | -$326,788 | |||||
| D | 2023-12-20 | CERE | Dipietro Kenneth | CHRO | S - Sale+OE | $41.42 | -6,256 | 24,663 | -20% | -$259,144 | |||||
| D | 2023-12-20 | CERE | Akamine Scott | GC | S - Sale+OE | $41.42 | -7,072 | 7,237 | -49% | -$292,945 | |||||
| D | 2023-12-20 | CERE | Sanchez Ramiro | Chief Medical Officer | S - Sale+OE | $41.42 | -10,152 | 14,673 | -41% | -$420,528 | |||||
| D | 2023-12-20 | CERE | Altschuller Susan | CFO | S - Sale+OE | $41.42 | -13,808 | 16,913 | -45% | -$571,972 | |||||
| D | 2023-12-20 | CERE | Tregoning Kathleen | See Remarks | S - Sale+OE | $41.42 | -6,288 | 7,516 | -46% | -$260,469 | |||||
| D | 2023-12-15 | CERE | Sanchez Ramiro | Chief Medical Officer | S - Sale+OE | $41.39 | -7,500 | 0 | -100% | -$310,393 | |||||
| D | 2023-12-07 | CERE | Sanchez Ramiro | Chief Medical Officer | S - Sale+OE | $41.37 | -10,000 | 0 | -100% | -$413,700 | |||||
| DM | 2023-12-05 | CERE | Akamine Scott | GC | S - Sale+OE | $38.64 | -17,500 | 513 | -97% | -$676,200 | |||||
| D | 2023-11-14 | CERE | Coles N Anthony | Dir | S - Sale+OE | $25.13 | -22,824 | 2,704 | -89% | -$573,455 | |||||
| DM | 2023-11-07 | CERE | Coles N Anthony | Dir | S - Sale+OE | $25.02 | -27,176 | 2,704 | -91% | -$680,071 | |||||
| DM | 2023-11-02 | CERE | Coles N Anthony | Dir | S - Sale+OE | $25.34 | -100,000 | 2,704 | -97% | -$2,533,697 | |||||
| D | 2023-11-01 | CERE | Patrick Deval L | Dir | S - Sale+OE | $25.00 | -30,130 | 3,282 | -90% | -$753,250 | |||||
2023-10-16 | CERE | Gordon Christopher R | Dir, 10% | P - Purchase | $22.81 | +5,480,052 | 65,683,063 | +9% | +$124,999,986 | ||||||
2023-10-16 | CERE | Koppel Adam | Dir, 10% | P - Purchase | $22.81 | +5,480,052 | 65,683,063 | +9% | +$124,999,986 | ||||||
2023-10-16 | CERE | Bain Capital Investors LLC | 10% | P - Purchase | $22.81 | +5,480,052 | 65,679,781 | +9% | +$124,999,986 | ||||||
2023-10-16 | CERE | Perceptive Advisors LLC | Dir | P - Purchase | $22.81 | +876,808 | 10,965,193 | +9% | +$19,999,990 | ||||||
| D | 2023-09-07 | CERE | Coles N Anthony | Dir | S - Sale+OE | $24.07 | -50,000 | 2,704 | -95% | -$1,203,415 | |||||
2023-08-03 | CERE | Renaud Ronald C Jr | Pres, CEO | P - Purchase | $23.96 | +83,857 | 83,857 | New | +$2,008,811 | ||||||
2023-08-04 | CERE | Burgess Paul D. | See Remarks | P - Purchase | $22.93 | +21,880 | 21,880 | New | +$501,794 | ||||||
| D | 2023-07-11 | CERE | Coles N Anthony | Dir | S - Sale+OE | $30.03 | -50,000 | 2,704 | -95% | -$1,501,340 | |||||
2023-06-15 | CERE | Dekkers Marijn E | Dir | S - Sale | $34.43 | -200,000 | 434,148 | -32% | -$6,886,000 | ||||||
| D | 2023-06-01 | CERE | Coles N Anthony | CEO, Chairperson | S - Sale+OE | $32.60 | -50,000 | 2,704 | -95% | -$1,630,070 | |||||
| D | 2023-06-02 | CERE | Bodenrader Mark | See Remarks | S - Sale+OE | $32.95 | -1,895 | 5,522 | -26% | -$62,440 | |||||
| D | 2023-05-04 | CERE | Coles N Anthony | CEO, Chairperson | S - Sale+OE | $31.47 | -50,000 | 2,704 | -95% | -$1,573,434 | |||||
| D | 2023-04-11 | CERE | Coles N Anthony | CEO, Chairperson | S - Sale+OE | $25.06 | -50,000 | 2,704 | -95% | -$1,253,130 | |||||
| DM | 2023-03-02 | CERE | Coles N Anthony | CEO, Chairperson | S - Sale+OE | $27.12 | -50,000 | 2,704 | -95% | -$1,355,947 | |||||
| D | 2023-02-07 | CERE | Coles N Anthony | CEO, Chairperson | S - Sale+OE | $33.13 | -50,000 | 2,704 | -95% | -$1,656,401 | |||||
| D | 2023-01-05 | CERE | Coles N Anthony | CEO, Chairperson | S - Sale+OE | $29.94 | -50,000 | 2,704 | -95% | -$1,496,871 | |||||
| D | 2022-12-09 | CERE | Coles N Anthony | CEO, Chairperson | S - Sale+OE | $26.67 | -50,000 | 2,704 | -95% | -$1,333,300 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |